SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 5/06/21 Weis Markets Inc. 10-Q 3/27/21 46:4.4M |
Document/Exhibit Description Pages Size 1: 10-Q Weis Markets, Inc. 10Q 01 2021 HTML 529K 2: EX-31.1 Weis Markets, Inc. 10Q 01 2021 Exhibit 31.1 HTML 22K 3: EX-31.2 Weis Markets, Inc. 10Q 01 2021 Exhibit 31.2 HTML 22K 4: EX-32 Weis Markets, Inc. 10Q 01 2021 Exhibit 32 HTML 16K 11: R1 Document and Entity Information HTML 68K 12: R2 Consolidated Balance Sheets HTML 104K 13: R3 Consolidated Balance Sheets (Parenthetical) HTML 26K 14: R4 Consolidated Statements of Income HTML 57K 15: R5 Consolidated Statements of Comprehensive Income HTML 37K 16: R6 Consolidated Statements of Comprehensive Income HTML 19K (Parenthetical) 17: R7 Consolidated Statements of Shareholders' Equity HTML 36K 18: R8 Consolidated Statements of Cash Flows HTML 83K 19: R9 Consolidated Statements of Cash Flows HTML 18K (Parenthetical) 20: R10 Significant Accounting Policies HTML 17K 21: R11 Current Relevant Accounting Standards HTML 23K 22: R12 Marketable Securities HTML 185K 23: R13 Accumulated Other Comprehensive Income HTML 63K 24: R14 Long-Term Debt HTML 20K 25: R15 Revenue Recognition HTML 70K 26: R16 Leases HTML 42K 27: R17 Covid-19 HTML 18K 28: R18 Significant Accounting Policies (Policy) HTML 16K 29: R19 Current Relevant Accounting Standards (Policy) HTML 16K 30: R20 Marketable Securities (Tables) HTML 175K 31: R21 Accumulated Other Comprehensive Income (Tables) HTML 63K 32: R22 Revenue Recognition (Tables) HTML 65K 33: R23 Leases (Tables) HTML 37K 34: R24 Marketable Securities (Narrative) (Details) HTML 23K 35: R25 Marketable Securities (Schedule Of Marketable HTML 35K Securities) (Details) 36: R26 Marketable Securities (Schedule Of Maturities Of HTML 36K Marketable Securities) (Details) 37: R27 Accumulated Other Comprehensive Income (Schedule HTML 28K Of Accumulated Other Comprehensive Income) (Details) 38: R28 Accumulated Other Comprehensive Income (Schedule HTML 33K Of Reclassifications out of Accumulated Other Comprehensive Income) (Details) 39: R29 Long-Term Debt (Narrative) (Details) HTML 33K 40: R30 Revenue Recognition (Schedule Of Sales By Type Of HTML 35K Product) (Details) 41: R31 Leases (Narrative) (Details) HTML 21K 42: R32 Leases (Schedule Of Lease Costs) (Details) HTML 23K 44: XML IDEA XML File -- Filing Summary XML 77K 10: XML XBRL Instance -- wmk-20210327x10q_htm XML 927K 43: EXCEL IDEA Workbook of Financial Reports XLSX 39K 6: EX-101.CAL XBRL Calculations -- wmk-20210327_cal XML 131K 7: EX-101.DEF XBRL Definitions -- wmk-20210327_def XML 158K 8: EX-101.LAB XBRL Labels -- wmk-20210327_lab XML 510K 9: EX-101.PRE XBRL Presentations -- wmk-20210327_pre XML 393K 5: EX-101.SCH XBRL Schema -- wmk-20210327 XSD 69K 45: JSON XBRL Instance as JSON Data -- MetaLinks 215± 298K 46: ZIP XBRL Zipped Folder -- 0000105418-21-000031-xbrl Zip 101K
WEIS MARKETS, INC 10Q 1 2021 Exhibit 311 |
WEIS MARKETS, INC.
CERTIFICATION- CHIEF EXECUTIVE OFFICER
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jonathan H. Weis, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Weis Markets, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
Date: |
|
||
|
|
|
|
|
|
|
Chairman, |
|
|
|
President and Chief Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/6/21 | None on these Dates | ||
For Period end: | 3/27/21 | |||
List all Filings |